Watchlist Price Alert

GRI Bio Inc. (GRI)

NASDAQ: GRI · Real-Time Price · USD

2.08

-0.02 (-0.95%)

At close: May 05, 2025, 3:50 PM

GRI Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q4 2019
Period Ending	Jan 31, 2025	Oct 31, 2024	Jul 31, 2024	Apr 30, 2024	Jan 31, 2024	Sep 30, 2023	Jun 30, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Dec 31, 2019
Cash & Equivalents	5.03M	4.75M	6.35M	4.09M	1.81M	3.49M	4.8M	3.78M	4.73M	5.22M	2.54M	3.7M	5.88M	10.46M	12.98M	109K	924K	2M	3.82M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	419K	1.75M	2.63M	3.81M	3.25M	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	-1	n/a	n/a	n/a	169K	187K	n/a	224K	243K	n/a	-1	n/a	n/a	-1
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	587K	577K	531K	337K	1.13M	879K	793K	371K	418K	868K	580K	619K	778K	944K	1.36M	565K	383K	118K	100.86K
Total Current Assets	5.62M	5.32M	6.88M	4.43M	2.93M	4.37M	5.59M	4.15M	5.57M	7.84M	5.76M	8.13M	9.92M	11.4M	14.34M	674K	1.31M	2.12M	3.92M
Property-Plant & Equipment	124K	136K	147K	159K	22K	37K	50K	n/a	n/a	n/a	n/a	206K	n/a	n/a	262K	281K	300K	318K	353.9K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	124K	136K	147K	159K	22K	37K	50K	n/a	n/a	169K	187K	206K	224K	243K	262K	281K	300K	318K	353.9K
Total Assets	5.74M	5.46M	7.03M	4.59M	2.96M	4.4M	5.64M	4.15M	5.57M	8.01M	5.94M	8.34M	10.14M	11.65M	14.6M	955K	1.61M	2.44M	4.28M
Account Payables	897K	1.14M	1.24M	637K	1.41M	988K	307K	977K	1.19M	1.81M	1.23M	918K	488K	886K	1.35M	1.23M	519K	508K	246.33K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	52K	57K	62K	67K	71K	76K	81K	n/a	90K	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	28K	41K	n/a	n/a	n/a	n/a	97K	n/a	n/a	95K	152K	126K	106K	85.67K
Other Current Liabilities	354K	n/a	n/a	1K	3K	281K	394K	432K	628K	2.18M	842K	1.08M	466K	518K	733K	424K	769K	171K	255.81K
Total Current Liabilities	1.64M	1.72M	2.22M	1.68M	2.7M	2.18M	1.6M	1.81M	2.11M	4.32M	2.54M	2.44M	1.31M	1.67M	2.43M	2.23M	1.41M	1.22M	807.5K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	14K	24K	34K	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	19K	46K	n/a	98K	123K	-1	-1	n/a	n/a	n/a
Total Long-Term Liabilities	71K	84K	96K	109K	n/a	n/a	n/a	n/a	n/a	19K	46K	72K	98K	123K	146K	184K	217K	248K	254.36K
Total Liabilities	1.71M	1.8M	2.31M	1.79M	2.7M	2.18M	1.6M	1.81M	2.11M	4.34M	2.58M	2.52M	1.41M	1.79M	2.57M	2.41M	1.63M	1.47M	1.06M
Total Debt	119K	131K	141K	152K	14K	28K	41K	n/a	n/a	n/a	n/a	169K	n/a	n/a	241K	336K	343K	354K	340.02K
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1K	1K	1K	n/a	n/a	n/a	n/a	n/a	n/a	18K	18K	18.02K
Retained Earnings	-39.74M	-37.79M	-35.67M	-33.42M	-31.53M	-29.53M	-27.39M	-28.93M	-27.34M	-26.31M	-24.54M	-21.9M	-18.81M	-17.55M	-15.24M	-12.6M	-11.13M	-10.09M	-7.78M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1K	-3K	-6K	-2K	-1K	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	4.03M	3.66M	4.72M	2.8M	259K	2.23M	4.04M	2.34M	3.46M	3.67M	3.36M	5.82M	8.73M	9.85M	12.03M	-1.45M	-24K	969K	3.21M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	419K	1.75M	2.63M	3.81M	3.25M	n/a	n/a	n/a	n/a	n/a	n/a